Cannabinoids and neuroinflammation
Article first published online: 30 JAN 2009
DOI: 10.1038/sj.bjp.0705667
2004 British Pharmacological Society
Additional Information
How to Cite
Walter, L. and Stella, N. (2004), Cannabinoids and neuroinflammation. British Journal of Pharmacology, 141: 775–785. doi: 10.1038/sj.bjp.0705667
Publication History
- Issue published online: 30 JAN 2009
- Article first published online: 30 JAN 2009
- (Received October 8, 2003, Revised November 7, 2003, Accepted December 11, 2003)
- Abstract
- Article
- References
- Cited By
Keywords:
- Cannabinoid;
- glia;
- immune cells;
- inflammation;
- multiple sclerosis
Growing evidence suggests that a major physiological function of the cannabinoid signaling system is to modulate neuroinflammation. This review discusses the anti-inflammatory properties of cannabinoid compounds at molecular, cellular and whole animal levels, first by examining the evidence for anti-inflammatory effects of cannabinoids obtained using in vivo animal models of clinical neuroinflammatory conditions, specifically rodent models of multiple sclerosis, and second by describing the endogenous cannabinoid (endocannabinoid) system components in immune cells. Our aim is to identify immune functions modulated by cannabinoids that could account for their anti-inflammatory effects in these animal models.
British Journal of Pharmacology (2004) 141, 775–785. doi:10.1038/sj.bjp.0705667

1476-5381/asset/olbannerleft.gif?v=1&s=198ba9e64c782a75183a18cb494f9d10ecc901ea)
1476-5381/asset/olbannerright.gif?v=1&s=0b2124237bd4227e7991f1ea05cd4bed2496a9ae)
1476-5381/asset/cover.gif?v=1&s=f56f5a76559ff1cebf2b6e329fe028f1e9e0f463)